Greenland Mines Ltd. (GRML) focuses on developing innovative therapeutic solutions to combat neurodegenerative diseases. The company's primary treatment modalities involve cutting-edge cell and gene therapies. Joseph Sinkule founded this enterprise on August 2, 2004, and its corporate operations are based in Omaha, Nebraska.